Spaverin 40 mg, Tabletten - 20 Swissmedic Key 68410001 Registration Holder MEDITOP Switzerland AG Name Spaverin 40 mg, Tabletten Date of registration 30.01.2023 Introduction of Sequence 30.01.2023 ATC-Classification Drotaverine (A03AD02) Revision date WHO WHO-DDD Valid until 29.01.2028 Index Therapeuticus (BSV) Show package size 20 Index Therapeuticus (Swissmedic) 04.02. Description Swissmedic categorie. B SL Eintrag No Indication Information for professionals IP Consumer information CI Ex-factory-Price PR Deductible k.A. Consumer price PR Feedback FB GTIN 7680684100017 Medication Code Synthetika Pharmacode Disponibility
Composition drotaverini hydrochloridum 40 mg, lactosum monohydricum 20 mg, cellulosum microcristallinum, povidonum K 29-32, maydis amylum, magnesii stearas, talcum, pro compresso obducto. Packungsbestandteile Galenic Form Tablets Active Agent Dose Drotaverini Hydrochloridum 40 mg
Inactive agents Dose Cellulosum Microcristallinum Lactose Monohydrate 20 mg Magnesii Stearas Maydis Amylum Povidonum K 29-32 Pro Compresso Obducto Talcum
Source Data was imported : 08.11.2023
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
